APC and colorectal carcinoma: Interestingly, LiCl treatment not only upregulates β-catenin protein but also activates β-catenin reporter activity in CRC cells despite genetic mutations in CTNNB1/β-catenin or APC of CRC cells (Supplementary Figure 2).